Mối Quan Hệ Giữa Loại Hình Khối U và Tỷ Lệ Sống Của Bệnh Nhân Ung Thư Đại Tràng T2-T3 Không Có Hạch Bạch Huyết Được Điều Trị Bằng Kỹ Thuật Cắt Bỏ Toàn Bộ Mô Sau Khớp Giữ Nghịch

Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery- the clue to pelvic recurrence? Br J Surg 69:613–616 Dorudi S, Steele RJ, McArdle CS (2002) Surgery for colorectal cancer. Br Med Bull 64:101–118 Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 47:1145–1149 Colquhoun P, Wexner SD, Cohen A (2003) Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision. J Surg Oncol 83:133–139 Merchant NB, Guillem JG, Paty PB et al (1999) T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 3:642–647 Price T, Pittman K, Patterson W et al (2008) Management and survival trends in colorectal cancer. Clin Oncol 20:626–630 Jass JR, Love S, Northover JM (1987) A new prognostic classification for rectal cancer. Lancet 1:1303–1306 Jass JR, O’Brien MJ, Riddel HR et al (2007) Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Virchows Arch 450:1–13 Szynglarewicz B, Matkowski R, Forgacz J et al (2007) Clinical factors in prediction of prognosis after anterior resection with total mesorectal excision for carcinoma of the rectum. Oncol Rep 17:471–476 Katsumata D, Fukui H, Ono Y et al (2008) Depth of tumor invasion in locally advanced rectal cancer correlates with patient’s prognosis: the usefulness of elastic stain for its measurement. Surg Today 38:115–122 Bori R, Sejben I, Svebis M et al (2009) Heterogeneity of pT3 colorectal carcinomas according to the depth of invasion. Pathol Oncol Res (in press). doi 10.1007/s12253-009-9149-x Miyoshi M, Ueno H, Hashiguchi Y et al (2006) Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 243:492–498 Yoshida K, Yoshimatsu K, Otani T et al (2008) The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Anticancer Res 28:1773–1778 Szynglarewicz B, Matkowski R, Maciejczyk A et al (2008) Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient’s age and long-term outcome. J Gastrointestin Liver Dis 17:49–52 Compton CC (2003) Colorectal carcinoma: Diagnostic, Prognostic, and Molecular Features. Mod Pathol 16:376–388 Nagtegaal I, Gaspar C, Marijnen C et al (2004) Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol 204:183–292 Sternberg A, Mizrahi A, Amar M, Groisman G (2006) Detection of venous invasion in surgical specimens of colorectal carcinoma: the efficacy of various types of tissue blocks. J Clin Pathol 59:207–210 Harrison JC, Dean PJ, el-Zeky F et al (1994) From Dukes to Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 25:498–505 Quirke P, Dixon MF, Clayden AD et al (1987) Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 151:285–291 Scott NA, Rainwater LM, Wieand HS et al (1987) The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 30:513–520 Secco GB, Fardelli R, Campora E et al (1990) Prognostic value of Jass’ histological classification in left colon and rectal cancer: a multivariate analysis. Digestion 47:71–80 Ueno H, Jones A, Jass JR, Talbot IC (2002) Clinicopathological significance of the “keloid-like” collagen and myxoid stroma in advanced rectal cancer. Histopathology 40:327–334 Cianchi F, Messerini L, Palomba A et al (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40:1170–1175 Jimenez-Anula J, Luque RJ, Gaforio JJ, Delgado M (2005) Prognostic value of invasive growth pattern in sporadic colorectal cancer. Cir Esp 77:337–342 Shimomura T, Ishiguro S, Konishi H et al (2004) New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion. J Gastroenterol Hepatol 19:48–55 De Quay N, Cerottini JP, Albe X et al (1999) Prognosis in Dukes’ B colorectal carcinoma: the Jass classification revisited. Eur J Surg 65:588–592 Ilyas M, Novelli M, Wilkinson K et al (1997) Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes’ B colorectal cancers. J Clin Pathol 50:218–222 Gagliardi G, Stepniewska KA, Hershman MJ et al (1995) New grade-related prognostic variable for rectal cancer. Br J Surg 82:599–602 Neoptolemos JP, Oates GD, Newbold KM et al (1995) Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes’ or Jass’ classifications for colorectal cancer. Br J Surg 82:184–187 LiDestri G, Rinzivillo C, Vasquez E et al (2001) Evaluation of the prognostic accuracy of Astler-Coller’s and Jass’ classifications of colorectal cancer. Tumori 87:127–129 Fisher ER, Robinsky B, Sass R, Fisher B (1989) Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Dis Colon Rectum 32:944–949 Deans GT, Heatley M, Anderson N et al (1994) Jass’ classification revisited. J Am Coll Surg 179:11–17 Dundas SA, Laing RW, O’Cathain A et al (1988) Feasibility of new prognostic classification for rectal cancer. J Clin Pathol 41:1273–1276 Jass JR, Ajioka Y, Allen JP et al (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543–548